Tag: AAPT

RENU, TLON, ICNB & Today’s Extended Watchlist

Renuen Corp RENU

Our interest in RENU has been renewed. Yesterday, the stock was able to break resistance at the 50 & 100DMA’s as we had expressed hope for in our morning report, touching .004 at one point. Being as low as .0015 last week, gains on the order of 167% were possible.

As you can see on the chart below, the RSI has surpassed the 50-line and the 50DMA. The blue bars on the histogram flipped up to the bullish side, we can see a PPO crossover, and the Slow STO has passed through the 50MA overlay. All of this on increasing volume, leads us to a bullish opinion of RENU.

NEW YORK, NY and ST. CLOUD, FL–(Marketwire -07/26/12)- RenuEn Corporation (RENU), a rapidly expanding renewable energy roll-up company focused on solar, wind and geothermal energy solutions, today announced that the Company has signed a Letter of Intent to acquire Team Energy, Inc., a developer of renewable energy projects based in St. Cloud, Florida. >>FULL STORY

____

Talon Therapeutics, Inc. TLON

TLON enjoyed another nice day of gains on Wednesday, hitting a new 52-week high. We began mentioning it a couple of weeks back (July 11th), at which time the stock was trading as low as 1.28. Yesterday’s high of 1.72, marks a gain of 34%

Just a reminder, TLON has an upcoming FDA date on August 12th.

____

Iconic Brands, Inc. ICNB

We have our eye on ICNB as a momentum play. The stock was up considerably yesterday and Tuesday, with 700% in gains rolling in during that short time. We just want to keep it on the radar in case it keeps moving. The company released a corporate update yesterday, included here:

NEW YORK, Jul 25, 2012 (BUSINESS WIRE) — Iconic Brands, Inc. (Iconic) (OTCBB: ICNB) announces corporate updates as related to ongoing operations and forward looking plans. As previously announced in September of last year our wholly owned subsidiary, Iconic Imports Inc. was forced to file chapter 7 bankruptcy when a senior creditor foreclosed on the subsidiary assets. The bankruptcy hearing has been held without claim and is pending discharge. There is no effect on the capital structure; the company maintains approximately 52 million shares outstanding with approximately 20 million in the public float.

In the interim we have aggressively started the process to update our financials and engage in new business opportunities to create value for our shareholders. We anticipate having all of the financials updated by no later than the third quarter ending September 30th, 2012. We have put up a simple website to provide information while going through this process. www.icnb.info

____

Today is the FDA PDUFA date for Horizon Pharma, Inc HZNP

The FDA will rule on HZNP’s RAYOS modified-release low dose prednisone. We have done considerably well with HZNP leading into today’s upcoming verdict, thus, it may be a good idea for us to take profits off of the table, in the event of no approval.

___

Extended Watchlist:
IWDM, IMDS, BBDA, AAPT, NOK

IDOI, CMG & Today’s Extended Watchlist

IDO Security, Inc. IDOI &

We continue our coverage of IDOI this morning, after the stock made some impressive moves last week. Being as low as .40 on Thursday, we saw Friday’s close come in at .62, just one tick down from the high of day at .63. Total possible gain, 56%

Considering the post-market PR that came across the wires on Friday, we are observing for continued momentum. Untraded-upon news can often have a big effect, and we want to be sure to maximize our profits here.

We have provided yet another of our video presentations of the chart for your viewing convenience:

In an age when tragedies such as that which occurred this past weekend in Colorado seem to happen with increasing frequency, security is a concern at the top many people’s lists. A company like IDOI is poised to serve growing demand for added security measures in all public venues.
____

Chipotle Mexican Grill, Inc. CMG

CMG stock fell 20% (Down 86.00/share) as a result of their recent earnings report, thus we are looking bounce activity on CMG options.

The $350 07/27 Calls closed at .40 on Friday. The $350 08/18 Calls closed at 2.54. Provided the stock can recover some of its lost ground, and get back above its 200DMA (373.33), those options are going to work out very well. Therefore, we will be watching closely for the stock’s recovery.

____

Extended Watchlist:

WAVX, BBDA, YIPI, GEN, AAPT, BFGC, LLTP

TLON (FDA PDUFA 08/12/2012)

HZNP (FDA PDUFA 07/27/2012)

ICPA, TLON & Today’s Extended Watchlist

We’d like to extend a big welcome to all of our new subscribers! Get ready for a new way of doing things! You made a great choice in signing on with us, and will soon notice that we’re not your average stock newsletter. We provide our readers with play after play, day after day, with little regard for our own interests. All we really care about is bringing you the best product we can, through careful coverage of many stocks at once. More often than not, we cover these stocks for long periods of time, waiting for just the right moment. Take our first mention today, ICPA. We have been on this one for a very long time, and have had our patience rewarded highly on more than one occasion as a result:

IC Places, Inc. ICPA

Our first mention of ICPA in the newsletter came on January 9th. At the time, the stock was trading as low as .0008, and since that time, the stock has provided us with many opportunities to gain as the one year chart shows.

At one point in the beginning of May, a high of .0585 was attained, however the nature of trading on this stock has given us the chance to rake in more than just the astonishing gain from triple-zero range to a nickel. Subsequent to that run, the stock pulled back to find support in the .02’s only to turn around and hit the nickel-range once again. ICPA has been a veritable cash cow for us at times, so our newest members will become familiar with this stock.

After another recent pullback in late June, we saw support form at the 200DMA (.0112).  ICPA now has broken the 100DMA at .0185, which we’d like to see become the new support. .

____

Talon Therapeutics, Inc. TLON

We picked up on this upcoming FDA play, and wanted to pass it along to you today. TLON is likely to become a target for many investors as we approach August 12, the company’s FDA PDUFA for their Phase III drug candidate Marqibo.

Some of you will remember ARNA, a recent FDA play that we covered quite successfully. The stock ran into its approval date, and scored approval, along with a serious surge in PPS. (5.44-13.50 in just about a month and a half)

If TLON enjoys even a fraction of the success garnered by ARNA, we’re in for quite a ride in coming weeks.

____

Extended Watchlist:
CLSP, NGSX (Bottom Bouncer), AAPT